Data / Form D filings / Coya Therapeutics, Inc.
Coya Therapeutics, Inc.: Form D filings
Coya Therapeutics, Inc., a biotechnology company in Houston, TX, filed 4 Form D notices with the SEC between 2021 and 2024. The latest, on October 28, 2024, reports $10 million sold of a $10 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5850 SAN FELIPE ST., SUITE 500, Houston, TX, 77057
- Phone
- (650) 739-3939
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1835022
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 28, 2024 | New notice | $10,000,026 | $10,000,026 | 9 | Oct 23, 2024 | sec.gov | |
| Dec 20, 2023 | New notice | $26,484,515 | $26,484,515 | 122 | Dec 5, 2023 | sec.gov | |
| May 20, 2022 | New notice | $20,000,000 | $10,443,970 | $9,556,030 | 45 | Apr 5, 2022 | sec.gov |
| Jan 5, 2021 | New notice | $10,000,000 | $10,000,000 | 57 | Dec 22, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Snyder | Executive Officer | |
| Hideki Garren | Director | |
| Anabella Villalobos | Director | |
| Dieter Weinand | Director | |
| Ann Lee | Director | |
| Fred Grossman | Executive Officer | |
| Dov Goldstein | Director | |
| Wilbur Ross | Director | |
| Howard Berman | Executive Officer, Director | |
| Arun Swaminathan | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Oct 28, 2024 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Coya Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.